We are live on ! Find out more
QUSVM

Qiming U.S. Ventures Management Portfolio holdings

AUM $55.6M
1-Year Est. Return 98.09%
This Fund
S&P 500
This Quarter Est. Return
+47.79%
1 Year Est. Return
+98.09%
3 Year Est. Return
+1,484.17%
5 Year Est. Return
10 Year Est. Return
AUM
$75.6M
AUM Growth
+$6.75M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
7
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICVX
1
DELISTED
Icosavax, Inc. Common Stock
ICVX
$27.9M 36.87%
3,510,228
VTYX
2
DELISTED
Ventyx Biosciences
VTYX
$24.5M 32.37%
746,370
HLVX
3
DELISTED
HilleVax
HLVX
$9.35M 12.37%
558,923
KZR
4
DELISTED
Kezar Life Sciences
KZR
$5.83M 7.72%
82,871
TRML
5
DELISTED
Tourmaline Bio
TRML
$2.99M 3.96%
293,261
JSPR icon
6
Jasper Therapeutics
JSPR
$22.4M
$2.83M 3.74%
585,298
ELEV
7
DELISTED
Elevation Oncology
ELEV
$2.25M 2.98%
2,370,142

Similar funds

Qiming U.S. Ventures Management's Q4 2022 Portfolio in Review

As of Q4 2022, Qiming U.S. Ventures Management held 7 positions worth $75.6M, up 9.8% from $68.8M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2022: portfolio turnover was 0%. Qiming U.S. Ventures Management opened no new positions and made no exits, leaving the 7-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Qiming U.S. Ventures Management's ten largest holdings make up 100% of its $75.6M portfolio in Q4 2022.
  • Qiming U.S. Ventures Management opened 0 new positions and closed 0 in Q4 2022.
  • Qiming U.S. Ventures Management's portfolio value rose 9.8% quarter-over-quarter to $75.6M.

Based on Qiming U.S. Ventures Management's 13F filing for Q4 2022, filed 24 Jan 2023.